Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

计划入组 17 人 · 首次发布于 2024 年 8 月 23 日

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

计划入组 12 人 · 首次发布于 2024 年 12 月 27 日

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

计划入组 24 人 · 首次发布于 2009 年 5 月 28 日

natural killer cell therapy

Natural Killer Cell

Chimeric Natural Killer Receptor-Universal T Cells therapy(Fujian Medical University)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Natural Cycles

United Kingdom

Advancements in Natural Killer Cell Cancer Immunotherapy

UCLA Develops Off-the-Shelf CAR-NKT Cell Therapy for Ovarian Cancer Treatment

Indapta's IDP-023 Shows Promise in Multiple Myeloma and Enhanced NK Cell Activity